Leuko Labs, Inc. — Form D
Leuko Labs, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-15. The offering totals $1.7M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-02-15
- Form: D
- Accession: 0001766291-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.2M
- Remaining: $500K
- Investors: 14
- Date of first sale: 2019-02-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-333009
Issuer
- Name: Leuko Labs, Inc.
- CIK: 0001766291
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 8 ST. MARY'S STREET, BOSTON, MA, 02215
- Phone: 781-954-0250
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ian Castro Butterworth | Director | Boston, MA |
| Carlos Castro Gonzalez | Director | Boston, MA |
| Paul Castro Hartung | Director | Boston, MA |
| Amy Castro Salzhauer | Director | Boston, MA |
| Ian Castro Butterworth | Executive Officer | Boston, MA |
| Carlos Castro Gonzalez | Executive Officer | Boston, MA |
More